Table 1.
Total | ADM | No ADM | P | |
---|---|---|---|---|
Breasts | 76 | 35 | 41 | — |
Patients | 51 | 23 | 28 | — |
Age (y)* | 52.1 ± 1.2 | 51.4 ± 1.7 | 52.6 ± 1.7 | 0.735 |
Mean BMI (kg/m2)* | 27.2 ± 0.8 | 29.3 ± 1.2 | 25.4 ± 0.9 | 0.011 |
Diabetes mellitus | 6 (7.9%) | 3 (8.6%) | 3 (7.3%) | 1.000 |
Active tobacco use | 1 (1.3%) | 0 | 1 (2.4%) | 1.000 |
Former tobacco use | 22 (28.9%) | 9 (25.7%) | 13 (31.7%) | 0.566 |
Prior breast augmentation | 3 (3.9%) | 0 | 3 (7.3%) | 0.245 |
Prior breast reduction | 6 (7.9%) | 5 (14.3%) | 1 (2.4%) | 0.089 |
Prior lumpectomy | 16 (21.1%) | 7 (20.0%) | 9 (22.0%) | 0.835 |
Previous radiation | 8 (10.5%) | 2 (5.7%) | 6 (14.6%) | 0.275 |
Previous chemotherapy | 21 (27.6%) | 7 (20.0%) | 14 (34.1%) | 0.169 |
Postoperative radiation | 18 (23.7%) | 9 (25.7%) | 9 (22.0%) | 0.701 |
Postoperative chemotherapy | 25 (32.9%) | 13 (37.1%) | 12 (29.3%) | 0.466 |
Cancer stage | 0.202 | |||
k 0 | 15 (20.3%) | 4 (12.1%) | 11 (26.8%) | |
IA/IB | 25 (33.8%) | 13 (39.4%) | 12 (29.3%) | |
IIA/IIB | 21 (28.4%) | 8 (24.2%) | 13 (31.7%) | |
IIIA/IIIB/IIIC | 12 (16.2%) | 7 (21.2%) | 5 (12.2%) | |
IV | 1 (1.4%) | 1 (3.0%) | 0 | |
Follow-up length (mo)* | 16.0 ± 0.9 | 20.3 ± 1.5 | 12.3 ± 0.8 | 0.000 |
Follow-up length since exchange (mo)* | 11.1 ± 1.1 | 14.8 ± 1.8 | 8.6 ± 1.2 | 0.008 |
*Mean ± standard error of the mean.
Bold values are statistically significant.